Associations between serum vitamin D3, atherogenic indices of plasma and cardiometabolic biomarkers among patients with diabetes in the KERCADR study

Table 2 Mean ± SE and Interquartile Range^a of Serum 25(OH) Vit. D and Atherogenic Indices^b of Plasma of Participants according to Gender

	Total Participants (n = 252)		P value	Male (n = 136)		P value	Female (n = 116)		P value
	Case	Control	P value	Case (n = 69)	Control (n = 67)	P value	Case (n = 55)	Control (i61)	P value
Serum 25(OH)D^c	26.6 ± 1.1 (18.0)	25.8 ± 1.1 (17.75)	0.656	26.4 ± 1.3 (15.0)	26.1 ± 1.2 (13.0)	0.677	26.8 ± 2.1 (23.0)	25.6 ± 1.9 (23.0)	0.860
AIP	0.56 ± 0.03 (0.41)	0.39 ± 0.02 (0.35)	0.000	0.56 ± 0.03 (0.35)	0.43 ± 0.03 (0.37)	0.000	0.57 ± 0.04 (0.49)	0.35 ± 0.03 (0.34)	0.007
CRI I	4.45 ± 0.12 (1.58)	4.26 ± 0.08 (1.33)	0.200	4.44 ± 0.14 (1.75)	4.37 ± 0.12 (1.17)	0.174	4.47 ± 0.21 (1.60)	4.14 ± 0.12 (1.55)	0.706
CRI II	2.50 ± 0.09 (1.09)	2.68 ± 0.07 (1.17)	0.109	2.49 ± 0.10 (1.14)	2.74 ± 0.09 (0.93)	0.557	2.50 ± 0.15 (1.18)	2.61 ± 0.10 (1.27)	0.079
AC	3.45 ± 0.12 (1.58)	3.26 ± 0.08 (1.33)	0.200	3.44 ± 0.14 (1.75)	3.37 ± 0.12 (1.17)	0.174	3.47 ± 1.59 (1.60)	3.14 ± 0.12 (1.55)	0.706

^a Interquartile range is in bracket
^b Atherogenic Index of Plasma = AIP; Castelli Risk Index I=CRI I; Castelli Risk Index II=CRI II; Atherogenic Coefficient = AC
^c Based on ng/ml

ISSN: 1472-6823